Granahan Investment Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-493,364
| Closed | -$3.49M | – | 173 |
|
|
2024
Q4 | $3.49M | Sell |
493,364
-539,119
| -52% | -$3.81M | 0.15% | 130 |
|
|
2024
Q3 | $8.4M | Sell |
1,032,483
-10,250
| -1% | -$83.4K | 0.33% | 92 |
|
|
2024
Q2 | $6.66M | Sell |
1,042,733
-210,971
| -17% | -$1.35M | 0.27% | 101 |
|
|
2024
Q1 | $9.44M | Buy |
1,253,704
+19,983
| +2% | +$150K | 0.33% | 90 |
|
|
2023
Q4 | $11.4M | Buy |
1,233,721
+55,818
| +5% | +$517K | 0.38% | 82 |
|
|
2023
Q3 | $11.9M | Buy |
1,177,903
+17,678
| +2% | +$179K | 0.42% | 70 |
|
|
2023
Q2 | $14.5M | Buy |
1,160,225
+165,388
| +17% | +$2.07M | 0.45% | 69 |
|
|
2023
Q1 | $11.6M | Buy |
994,837
+185,352
| +23% | +$2.16M | 0.35% | 77 |
|
|
2022
Q4 | $8.6M | Buy |
809,485
+161,186
| +25% | +$1.71M | 0.26% | 98 |
|
|
2022
Q3 | $6.29M | Buy |
648,299
+82,501
| +15% | +$800K | 0.21% | 118 |
|
|
2022
Q2 | $8.2M | Buy |
565,798
+7,899
| +1% | +$114K | 0.28% | 95 |
|
|
2022
Q1 | $14.6M | Buy |
557,899
+134,427
| +32% | +$3.51M | 0.36% | 72 |
|
|
2021
Q4 | $16.8M | Buy |
423,472
+242,058
| +133% | +$9.59M | 0.35% | 79 |
|
|
2021
Q3 | $9.07M | Buy |
181,414
+30,988
| +21% | +$1.55M | 0.17% | 120 |
|
|
2021
Q2 | $8.35M | Buy |
150,426
+35,649
| +31% | +$1.98M | 0.16% | 123 |
|
|
2021
Q1 | $5.37M | Buy |
114,777
+4,573
| +4% | +$214K | 0.11% | 138 |
|
|
2020
Q4 | $4.8M | Buy |
110,204
+24,325
| +28% | +$1.06M | 0.11% | 134 |
|
|
2020
Q3 | $3.14M | Buy |
+85,879
| New | +$3.14M | 0.11% | 131 |
|